PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Infection and Immunity, University College London, London WC1E 6BT, UK.\', \'Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge CB2 0AW, UK.\', \'Diagnostics for the Real World EU, Chesterford Research Park, Saffron Walden CB10 1XL, UK.\', \'Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge CB2 0QQ, UK.\', \'Department of Medicine, University of Cambridge, Cambridge CB2 0AW, UK.\', \'Clinical Microbiology & Public Health Laboratory, Public Health England, Cambridge CB2 0QQ, UK.\', \'POC Testing, Department of Pathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.\', \'National Institutes for Health Research (NIHR) Cambridge Biomedical Research Centre, Cambridge CB2 0QQ, UK.\', \'NIHR Cambridge Clinical Research Facility, Cambridge CB2 0QQ, UK.\', \'Department of Statistics, Athens University of Economics and Business, 28is Oktovriou 76, 104 34 Athens, Greece.\', \'Department of Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.\', \'Massachusetts General Hospital, Boston, MA, USA.\', \'Harvard Medical School, Boston, MA, USA.\', \'Africa Health Research Institute, Durban 4001, South Africa.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1016/j.xcrm.2020.100062
?:hasPublicationType
?:journal
  • Cell reports. Medicine
is ?:pmid of
?:pmid
?:pmid
  • 32838340
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Point of Care Nucleic Acid Testing for SARS-CoV-2 in Hospitalized Patients: A Clinical Validation Trial and Implementation Study.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all